These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 33739782)
41. Cerebellar Pleomorphic Xanthoastrocytoma with BRAF V600E Mutation. Kim SH; Hwang K; Lee KS; Choe G; Kim CY World Neurosurg; 2020 Jul; 139():577-581. PubMed ID: 32348888 [TBL] [Abstract][Full Text] [Related]
42. BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas. Lee D; Cho YH; Kang SY; Yoon N; Sung CO; Suh YL J Surg Oncol; 2015 Mar; 111(3):359-64. PubMed ID: 25346165 [TBL] [Abstract][Full Text] [Related]
43. [BRAF V600E mutation and clinicopathologic characteristics in 250 cases of brain tumors associated with epilepsy]. Qi XL; Yao K; Duan ZJ; Bian Y; Ma Z; Piao YS; Gong LP Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):664-670. PubMed ID: 30220118 [No Abstract] [Full Text] [Related]
44. Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous. Pinto EM; Hamideh D; Bahrami A; Orr BA; Lin T; Pounds S; Zambetti GP; Pappo AS; Gajjar A; Agnihotri S; Broniscer A Acta Neuropathol; 2018 Aug; 136(2):315-326. PubMed ID: 29428974 [TBL] [Abstract][Full Text] [Related]
45. Epithelioid glioblastoma arising from pleomorphic xanthoastrocytoma with the BRAF V600E mutation. Tanaka S; Nakada M; Nobusawa S; Suzuki SO; Sabit H; Miyashita K; Hayashi Y Brain Tumor Pathol; 2014 Jul; 31(3):172-6. PubMed ID: 24894018 [TBL] [Abstract][Full Text] [Related]
46. Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors. Tegeder I; Thiel K; Erkek S; Johann PD; Berlandi J; Thatikonda V; Frühwald MC; Kool M; Jeibmann A; Hasselblatt M J Neurooncol; 2019 Jan; 141(1):43-55. PubMed ID: 30446899 [TBL] [Abstract][Full Text] [Related]
47. Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors. Ho DM; Shih CC; Liang ML; Tsai CY; Hsieh TH; Tsai CH; Lin SC; Chang TY; Chao ME; Wang HW; Wong TT BMC Med Genomics; 2015 Jun; 8():32. PubMed ID: 26109171 [TBL] [Abstract][Full Text] [Related]
48. Ewing Sarcoma and Atypical Teratoid Rhabdoid Tumor: A FISH and Immunohistochemical Comparison. Pacheco MC; Dolan M; Bendel A Pediatr Dev Pathol; 2017; 20(5):381-386. PubMed ID: 28382842 [TBL] [Abstract][Full Text] [Related]
49. Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor. Biegel JA; Fogelgren B; Wainwright LM; Zhou JY; Bevan H; Rorke LB Genes Chromosomes Cancer; 2000 May; 28(1):31-7. PubMed ID: 10738300 [TBL] [Abstract][Full Text] [Related]
50. BRAF-mutated pleomorphic xanthoastrocytoma is associated with temporal location, reticulin fiber deposition and CD34 expression. Koelsche C; Sahm F; Wöhrer A; Jeibmann A; Schittenhelm J; Kohlhof P; Preusser M; Romeike B; Dohmen-Scheufler H; Hartmann C; Mittelbronn M; Becker A; von Deimling A; Capper D Brain Pathol; 2014 Apr; 24(3):221-9. PubMed ID: 24345274 [TBL] [Abstract][Full Text] [Related]
51. Molecular Features and Prognostic Factors of Pleomorphic Xanthoastrocytoma: A Collaborative Investigation of the Tohoku Brain Tumor Study Group. Ono T; Sasajima T; Shimizu H; Natsumeda M; Kanamori M; Asano K; Beppu T; Matsuda K; Ichikawa M; Fujii Y; Ohkuma H; Ogasawara K; Sonoda Y; Saito K; Nobusawa S; Nakazato Y; Kitanaka C; Kayama T; Tominaga T; Neurol Med Chir (Tokyo); 2020 Nov; 60(11):543-552. PubMed ID: 33071274 [TBL] [Abstract][Full Text] [Related]
53. Targeted Next-Generation Sequencing Reveals Divergent Clonal Evolution in Components of Composite Pleomorphic Xanthoastrocytoma-Ganglioglioma. Lucas CG; Davidson CJ; Alashari M; Putnam AR; Whipple NS; Bruggers CS; Mendez JS; Cheshier SH; Walker JB; Ramani B; Cadwell CR; Sullivan DV; Lu R; Mirchia K; Van Ziffle J; Devine P; Goldschmidt E; Hervey-Jumper SL; Gupta N; Oberheim Bush NA; Raleigh DR; Bollen A; Tihan T; Pekmezci M; Solomon DA; Phillips JJ; Perry A J Neuropathol Exp Neurol; 2022 Jul; 81(8):650-657. PubMed ID: 35703914 [TBL] [Abstract][Full Text] [Related]
54. Role of a Promoter Mutation in TERT in Malignant Transformation of Pleomorphic Xanthoastrocytoma. Hosono J; Nitta M; Masui K; Maruyama T; Komori T; Yokoo H; Saito T; Muragaki Y; Kawamata T World Neurosurg; 2019 Jun; 126():624-630. PubMed ID: 30599247 [TBL] [Abstract][Full Text] [Related]
55. Atypical Teratoid/Rhabdoid Tumor of the Spinal Cord in a Child: Case Report and Comprehensive Review of the Literature. Babgi M; Samkari A; Al-Mehdar A; Abdullah S Pediatr Neurosurg; 2018; 53(4):254-262. PubMed ID: 29788028 [TBL] [Abstract][Full Text] [Related]
56. An adult with recurrent atypical teratoid rhabdoid tumor of the spine. Charles AJ; Smith VL; Goodwin CR; Johnson MO CNS Oncol; 2024 Jan; 13(1):CNS105. PubMed ID: 38380555 [TBL] [Abstract][Full Text] [Related]
57. Atypical teratoid/rhabdoid tumor with ganglioglioma-like differentiation: case report and review of the literature. Krishnan C; Vogel H; Perry A Hum Pathol; 2014 Jan; 45(1):185-8. PubMed ID: 24034858 [TBL] [Abstract][Full Text] [Related]
58. Rhabdoid tumors in patients conceived following ART: is there an association? Nemes K; Benesch M; Kolarova J; Johann P; Hasselblatt M; Thomas C; Bens S; Glaser S; Ammerpohl O; Liaugaudiene O; Sadeghipour A; von der Weid N; Schmid I; Gidding C; Erdreich-Epstein A; Khurana C; Ebetsberger-Dachs G; Lemmer A; Khatib Z; Hernández Marqués C; Pears J; Quehenberger F; Kordes U; Vokuhl C; Gerss J; Schwarz H; Bison B; Biegel JA; Siebert R; Frühwald MC Hum Reprod; 2023 Oct; 38(10):2028-2038. PubMed ID: 37553222 [TBL] [Abstract][Full Text] [Related]
59. Atypical Teratoid/Rhabdoid Sellar Tumor in an Adult with a Familial History of a Germline SMARCB1 Mutation: Case Report and Review of the Literature. Voisin MR; Ovenden C; Tsang DS; Gupta AA; Huang A; Gao AF; Diamandis P; Almeida JP; Gentili F World Neurosurg; 2019 Jul; 127():336-345. PubMed ID: 31004861 [TBL] [Abstract][Full Text] [Related]
60. Evaluation of EZH2 expression, BRAF V600E mutation, and CDKN2A/B deletions in epithelioid glioblastoma and anaplastic pleomorphic xanthoastrocytoma. Wang J; Liu Z; Cui Y; Liu Y; Fang J; Xu L; He Y; Du J; Su Y; Zou W; Xu Z; Li G J Neurooncol; 2019 Aug; 144(1):137-146. PubMed ID: 31214915 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]